CYRX
Cryoport, Inc.
NasdaqCMUSDEQUITY
Industrials
DELAYED
Last price
17.26
▲ 0.55 (3.29%)
MARKET · —
Price
Open
16.82
Prev close
16.71
Day high
17.20
Day low
16.33
Volume
1.02M
Market cap
$867.62M
P/E (TTM)
—
52W range
7.61 – 17.20
Trailing performance
Returnvs SPY
1W
+12.33%
+13.7%
1M
+6.86%
+3.1%
3M
+20.46%
+17.4%
6M
+102.96%
+91.9%
YTD
+78.44%
+66.1%
1Y
+97.81%
+77.8%
3Y
+31.57%
-42.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$867.62M
Enterprise value$749.22M
Revenue (TTM)$186.45M
Gross profit$87.77M
EBITDA$-3.46M
Net income$-40.90M
EPS (TTM)$-0.82
Free cash flow$-14.68M
Total cash$396.69M
Total debt$232.02M
Book value / share$8.78
Shares outstanding50.65M
Float45.95M
Short % of float5.94%
Dividend yield—
Beta (5Y)1.89
Valuation & profitability ratios
Trailing P/E—
Forward P/E-25.82
PEG ratio62.13
Price / sales—
Price / book1.95
EV / revenue4.02
EV / EBITDA-216.73
Gross margin47.08%
Operating margin-20.45%
Profit margin-20.05%
Return on equity-6.54%
Return on assets-2.39%
Debt / equity47.28
Current ratio2.08
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $176.18M | $228.38M | $233.25M | $237.28M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $70.30M | -$122.76M | -$107.59M | -$45.33M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $70.30M | -$122.76M | -$107.59M | -$45.33M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.18 | -0.20 | -9.1% |
| Mar 2026 | -0.19 | -0.19 | +1.8% |
| Dec 2025 | -0.21 | -0.17 | +17.6% |
| Sep 2025 | -0.19 | -0.13 | +31.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.17 | 3 | $48.69M | +10.1% |
| Next quarter | -0.17 | 3 | $50.04M | +10.1% |
| Current year | -0.77 | 3 | $195.48M | +11.0% |
| Next year | -0.66 | 3 | $214.92M | +10.0% |
Analyst targets & ownership
Mean target$19.33
High target$25.00
Low target$15.00
Implied upside12.01%
Analyst count9
ConsensusNONE
Strong buy / Buy1 / 7
Hold1
Sell / Strong sell0 / 0
Held by insiders3.86%
Held by institutions95.20%
Institutions holding246
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+101.26K
Net buying
Buy transactions
13
425.01K shares
Sell transactions
12
323.75K shares
Net transactions
+25
Buys less sells
Sell : buy shares
0.8 : 1
Mixed
Insider-held shares
1.95M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 11, 26 | SHELTON JERRELL WILSON Chief Executive Officer |
SELL | 28.80K | $429.38K | Direct |
| Jun 11, 26 | ZECCHINI EDWARD J Officer |
CONVERSION | 35.00K | $168.00K | Direct |
| Jun 11, 26 | ZECCHINI EDWARD J Officer |
SELL | 35.00K | $507.56K | Direct |
| Jun 8, 26 | MANDALAM RAMKUMAR Director |
SELL | 23.21K | $358.45K | Direct |
| Jun 5, 26 | BADDOUR LINDA Director |
STOCK | 10.35K | $0 | Direct |
| Jun 5, 26 | HARIRI ROBERT J Director |
STOCK | 10.35K | $0 | Direct |
| Jun 5, 26 | MANDALAM RAMKUMAR Director |
STOCK | 10.35K | $0 | Direct |
| Jun 5, 26 | HANCOCK DANIEL M Director |
STOCK | 10.35K | $0 | Direct |
| Jun 4, 26 | STEFANOVICH ROBERT STEVEN Chief Financial Officer |
SELL | 169.43K | $2.76M | Direct |
| Apr 21, 26 | SHELTON JERRELL WILSON Chief Executive Officer |
CONVERSION | 104.01K | $194.49K | Direct |
| Apr 6, 26 | SHELTON JERRELL WILSON Chief Executive Officer |
CONVERSION | 50.00K | $93.50K | Direct |
| Mar 23, 26 | SHELTON JERRELL WILSON Chief Executive Officer |
CONVERSION | 25.00K | $46.75K | Direct |
| Mar 23, 26 | SAWICKI MARK W Officer |
SELL | 1.34K | $10.97K | Direct |
| Mar 23, 26 | STEFANOVICH ROBERT STEVEN Chief Financial Officer |
SELL | 1.09K | $8.95K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BADDOUR LINDA |
Director | 68.10K | Stock Award(Grant) |
HANCOCK DANIEL M |
Director | 69.05K | Stock Award(Grant) |
HARIRI ROBERT J |
Director | 61.63K | Stock Award(Grant) |
MANDALAM RAMKUMAR |
Director | 67.89K | Sale |
SAWICKI MARK W |
Officer | 102.36K | Sale |
SHELTON JERRELL WILSON |
Chief Executive Officer | 1.20M | Sale |
STEFANOVICH ROBERT STEVEN |
Chief Financial Officer | 109.85K | Sale |
ZECCHINI EDWARD J |
Officer | 109.72K | Conversion of Exercise of derivative security |
Moving averages & technicals
SMA 10
15.55
+10.99% from price
SMA 20
15.35
+11.61% from price
SMA 50
15.48
+10.67% from price
SMA 100
13.81
+25.02% from price
SMA 200
11.46
+49.44% from price
EMA 12
15.79
+9.33% from price
EMA 26
15.56
+10.94% from price
EMA 50
15.16
+13.84% from price
RSI (14)
67.5
Neutral
MACD (12,26,9)
0.23
Hist 0.21
ATR (14)
0.67
3.92% of price
Realised vol 30D
42.3%
Annualised
Bollinger upper
16.58
20, 2σ
Bollinger lower
14.11
20, 2σ
50 / 200 cross
Golden
15.48 vs 11.46
Trend bias
Above 200
+49.44%
Risk profile
Beta vs SPY
1.51
More volatile than market
Correlation to SPY
0.35
Loosely linked
Realised vol 30D
42.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-31.5%
Peak to trough
Max drawdown 5Y
-94.4%
Peak to trough
ATR 14
0.67
3.92% of price
Beta (reported)
1.89
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.10
Positioning, not flow
Max pain
12.50
-27.0% from spot
ATM implied vol
52.2%
Nearest strike to spot
Skew (10% OTM)
+95.4%
Puts bid over calls
Call volume
21
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
12.50
51 contracts
Heaviest put OI
12.50
10 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
Motley Fool · 9d ago
CryoPort (CYRX) Upgraded to Buy: Here's Why
Zacks · 11d ago
Investor Confidence in CryoPort (CYRX) Strengthened Backed by Pipeline Expansion
Insider Monkey · 15d ago
Cryoport, Inc. Q2 2026 Earnings Call Summary
Moby · 15d ago
CryoPort Inc (CYRX) (Q2 2026) Earnings Call Highlights: Positive EBITDA Milestone and 15% ...
GuruFocus.com · 16d ago
CryoPort Q2 Earnings Call Highlights
MarketBeat · 16d ago
CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates
Zacks · 16d ago
Cryoport Reports Second Quarter 2026 Financial Results
PR Newswire · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.